These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1128 related articles for article (PubMed ID: 19545249)
1. A randomized, double blind, placebo-controlled study of MAP0004 in adult patients with migraine. Aurora SK; Rozen TD; Kori SH; Shrewsbury SB Headache; 2009 Jun; 49(6):826-37. PubMed ID: 19545249 [TBL] [Abstract][Full Text] [Related]
2. MAP0004, orally inhaled DHE: a randomized, controlled study in the acute treatment of migraine. Aurora SK; Silberstein SD; Kori SH; Tepper SJ; Borland SW; Wang M; Dodick DW Headache; 2011 Apr; 51(4):507-17. PubMed ID: 21457235 [TBL] [Abstract][Full Text] [Related]
3. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets. Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of MAP0004, orally inhaled DHE in treating migraines with and without allodynia. Tepper SJ; Kori SH; Borland SW; Wang MH; Hu B; Mathew NT; Silberstein SD Headache; 2012 Jan; 52(1):37-47. PubMed ID: 22106843 [TBL] [Abstract][Full Text] [Related]
6. Diclofenac potassium liquid-filled soft gelatin capsules in the management of patients with postbunionectomy pain: a Phase III, multicenter, randomized, double-blind, placebo-controlled study conducted over 5 days. Riff DS; Duckor S; Gottlieb I; Diamond E; Soulier S; Raymond G; Boesing SE Clin Ther; 2009 Oct; 31(10):2072-85. PubMed ID: 19922878 [TBL] [Abstract][Full Text] [Related]
7. Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study). Mathew NT; Finlayson G; Smith TR; Cady RK; Adelman J; Mao L; Wright P; Greenberg SJ; Headache; 2007 Feb; 47(2):189-98. PubMed ID: 17300358 [TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults. Wendt J; Cady R; Singer R; Peters K; Webster C; Kori S; Byrd S Clin Ther; 2006 Apr; 28(4):517-26. PubMed ID: 16750463 [TBL] [Abstract][Full Text] [Related]
9. Zolmitriptan 5 mg nasal spray: efficacy and onset of action in the acute treatment of migraine--results from phase 1 of the REALIZE Study. Gawel M; Aschoff J; May A; Charlesworth BR; Headache; 2005 Jan; 45(1):7-16. PubMed ID: 15663607 [TBL] [Abstract][Full Text] [Related]
10. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study. Simpson DM; Messina J; Xie F; Hale M Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282 [TBL] [Abstract][Full Text] [Related]
11. Combination oxycodone 5 mg/ibuprofen 400 mg for the treatment of pain after abdominal or pelvic surgery in women: a randomized, double-blind, placebo- and active-controlled parallel-group study. Singla N; Pong A; Newman K; Clin Ther; 2005 Jan; 27(1):45-57. PubMed ID: 15763605 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of oxymorphone immediate release for acute postoperative pain after abdominal surgery: a randomized, double-blind, active- and placebo-controlled, parallel-group trial. Aqua K; Gimbel JS; Singla N; Ma T; Ahdieh H; Kerwin R Clin Ther; 2007 Jun; 29(6):1000-12. PubMed ID: 17692717 [TBL] [Abstract][Full Text] [Related]
13. Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study. Tepper SJ; Cady R; Dodick D; Freitag FG; Hutchinson SL; Twomey C; Kuhn TA Headache; 2006 Jan; 46(1):115-24. PubMed ID: 16412159 [TBL] [Abstract][Full Text] [Related]
14. Analgesic efficacy of celecoxib in postoperative oral surgery pain: a single-dose, two-center, randomized, double-blind, active- and placebo-controlled study. Cheung R; Krishnaswami S; Kowalski K Clin Ther; 2007; 29 Suppl():2498-510. PubMed ID: 18164917 [TBL] [Abstract][Full Text] [Related]
15. Randomized, double-blind, placebo-controlled study of the safety, tolerability and pharmacokinetics of MAP0004 (orally-inhaled DHE) in adult asthmatics. Shrewsbury SB; Kori SH; Miller SD; Pedinoff A; Weinstein S Curr Med Res Opin; 2008 Jul; 24(7):1977-85. PubMed ID: 18534051 [TBL] [Abstract][Full Text] [Related]
16. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life. Mathew NT; Landy S; Stark S; Tietjen GE; Derosier FJ; White J; Lener SE; Bukenya D Headache; 2009 Jul; 49(7):971-82. PubMed ID: 19486178 [TBL] [Abstract][Full Text] [Related]
17. Early intervention in migraine with sumatriptan tablets 50 mg versus 100 mg: a pooled analysis of data from six clinical trials. Winner P; Landy S; Richardson M; Ames M Clin Ther; 2005 Nov; 27(11):1785-94. PubMed ID: 16368449 [TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study. Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM; Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098 [TBL] [Abstract][Full Text] [Related]
19. Tramadol/acetaminophen for the treatment of acute migraine pain: findings of a randomized, placebo-controlled trial. Silberstein SD; Freitag FG; Rozen TD; Kudrow DB; Hewitt DJ; Jordan DM; Fisher AC; Rosenthal NR; Headache; 2005; 45(10):1317-27. PubMed ID: 16324164 [TBL] [Abstract][Full Text] [Related]